This randomized clinical trial studies how well couple-based meditation works in improving quality of life in patients with stage IV non-small cell lung cancer and their partners. Mind-body practices such as meditation and partner-assisted emotional disclosure may facilitate cancer adjustment and improve couples' quality-of life.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02596490.
Locations matching your search criteria
United States
Texas
Houston
Memorial Hermann Texas Medical CenterStatus: Active
Contact: Kathrin Milbury
Phone: 713-745-2868
UT MD Anderson Cancer CenterStatus: Active
Contact: Kathrin Milbury
Phone: 713-745-2868
PRIMARY OBJECTIVES:
I.: Examine the acceptability of the couple-based mindfulness disclosure (CBMD) program in patients with metastatic lung cancer (LC) and their partners.
II. Examine the feasibility of the CBMD program in patients with metastatic LC and their partners.
III. Establish the initial efficacy of the CBMD program in patients and their partners regarding physical,
psychological, and spiritual quality of life (QOL) outcomes.
EXPLORATORY OBJECTIVES:
I. Explore potential intervention mediators (i.e., mindfulness, compassion, holding back, and intimacy) and a moderator (i.e., baseline distress) of the intervention effects.
II. Explore natural language use to assess intervention effects on coping processes, posttraumatic growth and optimistic outlook.
III. Characterize the psychological adjustment of bereaved spouses following the patient’s death using qualitative and quantitative methods.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients and their partners attend one-on-one couple-based meditation practice sessions over 60-75 minutes once a week (QW) for 4 weeks.
ARM II: Patients and their partners attend one-on-one structured discussion sessions about cancer-related concerns with an interventionist over 60-75 minutes QW for 4 weeks.
After completion of study, patients are followed up at 1 and 3 months.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUT MD Anderson Cancer Center
Principal InvestigatorKathrin Milbury
